Skip to content
Politically.com Search all
Menu

2025 · 1st Quarter (Jan 1 - Mar 31)

NOVO NORDISK, INC.

Filed by THE NICKLES GROUP, LLC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
1st Quarter - Report
Posted
Apr 17, 2025
Income
$80,000.00
Expenses
Not reported
Filing UUID
f04183f7-2ec8-4416-8255-1db306d1c3d1
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to compounding and counterfeit drugs.

MMM · Medicare/Medicaid

Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications.

Literal federal measure citations: H.R. 1492

TAX · Taxation/Internal Revenue Code

Issues related to the extension of the Tax Cut and Jobs Act provisions impacting corporations. H.R. 591, Defending American Jobs and Investment Act, and H.R. 2423, Unfair Tax Prevention Act, as they relate to multinational corporations.

Literal federal measure citations: H.R. 591, H.R. 2423

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.